These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 18629676)

  • 1. Th17 cells: a new paradigm for cutaneous inflammation.
    Asarch A; Barak O; Loo DS; Gottlieb AB
    J Dermatolog Treat; 2008; 19(5):259-66. PubMed ID: 18629676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RORgamma-expressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17A and IL-17F.
    Leppkes M; Becker C; Ivanov II; Hirth S; Wirtz S; Neufert C; Pouly S; Murphy AJ; Valenzuela DM; Yancopoulos GD; Becher B; Littman DR; Neurath MF
    Gastroenterology; 2009 Jan; 136(1):257-67. PubMed ID: 18992745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokines that regulate autoimmunity.
    Diveu C; McGeachy MJ; Cua DJ
    Curr Opin Immunol; 2008 Dec; 20(6):663-8. PubMed ID: 18834938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-17 in inflammatory skin disorders.
    van Beelen AJ; Teunissen MB; Kapsenberg ML; de Jong EC
    Curr Opin Allergy Clin Immunol; 2007 Oct; 7(5):374-81. PubMed ID: 17873575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease.
    Brand S
    Gut; 2009 Aug; 58(8):1152-67. PubMed ID: 19592695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Th17 cytokines and their emerging roles in inflammation and autoimmunity.
    Fouser LA; Wright JF; Dunussi-Joannopoulos K; Collins M
    Immunol Rev; 2008 Dec; 226():87-102. PubMed ID: 19161418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developmental plasticity of Th17 and Treg cells.
    Lee YK; Mukasa R; Hatton RD; Weaver CT
    Curr Opin Immunol; 2009 Jun; 21(3):274-80. PubMed ID: 19524429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Th17 cells: a new therapeutic target in inflammatory dermatoses.
    Asarch A; Barak O; Loo DS; Gottlieb AB
    J Dermatolog Treat; 2008; 19(6):318-26. PubMed ID: 18626814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impairment of T helper and T regulatory cell responses at birth.
    Schaub B; Liu J; Schleich I; Höppler S; Sattler C; von Mutius E
    Allergy; 2008 Nov; 63(11):1438-47. PubMed ID: 18925880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homeostatic (IL-7) and effector (IL-17) cytokines as distinct but complementary target for an optimal therapeutic strategy in inflammatory bowel disease.
    Kanai T; Nemoto Y; Kamada N; Totsuka T; Hisamatsu T; Watanabe M; Hibi T
    Curr Opin Gastroenterol; 2009 Jul; 25(4):306-13. PubMed ID: 19448533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines.
    Ortega C; Fernández-A S; Carrillo JM; Romero P; Molina IJ; Moreno JC; Santamaría M
    J Leukoc Biol; 2009 Aug; 86(2):435-43. PubMed ID: 19487306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of the Th17 pathway and its role in host defense.
    O'Quinn DB; Palmer MT; Lee YK; Weaver CT
    Adv Immunol; 2008; 99():115-63. PubMed ID: 19117534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-21 (IL-21)-mediated pathways in T cell-mediated disease.
    Monteleone G; Pallone F; Macdonald TT
    Cytokine Growth Factor Rev; 2009 Apr; 20(2):185-91. PubMed ID: 19261537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The roles of IL-17A in inflammatory immune responses and host defense against pathogens.
    Iwakura Y; Nakae S; Saijo S; Ishigame H
    Immunol Rev; 2008 Dec; 226():57-79. PubMed ID: 19161416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GATA-3 protects against severe joint inflammation and bone erosion and reduces differentiation of Th17 cells during experimental arthritis.
    van Hamburg JP; Mus AM; de Bruijn MJ; de Vogel L; Boon L; Cornelissen F; Asmawidjaja P; Hendriks RW; Lubberts E
    Arthritis Rheum; 2009 Mar; 60(3):750-9. PubMed ID: 19248112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of IL-23-Th17 cell axis in allergic airway inflammation.
    Wakashin H; Hirose K; Iwamoto I; Nakajima H
    Int Arch Allergy Immunol; 2009; 149 Suppl 1():108-12. PubMed ID: 19494515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TLR2 is a negative regulator of Th17 cells and tissue pathology in a pulmonary model of fungal infection.
    Loures FV; Pina A; Felonato M; Calich VL
    J Immunol; 2009 Jul; 183(2):1279-90. PubMed ID: 19553529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 2-mediated conversion of ovarian cancer-associated CD4+ regulatory T cells into proinflammatory interleukin 17-producing helper T cells.
    Leveque L; Deknuydt F; Bioley G; Old LJ; Matsuzaki J; Odunsi K; Ayyoub M; Valmori D
    J Immunother; 2009; 32(2):101-8. PubMed ID: 19238008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fetal BM-derived mesenchymal stem cells promote the expansion of human Th17 cells, but inhibit the production of Th1 cells.
    Guo Z; Zheng C; Chen Z; Gu D; Du W; Ge J; Han Z; Yang R
    Eur J Immunol; 2009 Oct; 39(10):2840-9. PubMed ID: 19637224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IFN-beta1a inhibits the secretion of Th17-polarizing cytokines in human dendritic cells via TLR7 up-regulation.
    Zhang X; Jin J; Tang Y; Speer D; Sujkowska D; Markovic-Plese S
    J Immunol; 2009 Mar; 182(6):3928-36. PubMed ID: 19265172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.